Earned an MD from Uppsala University 1980 and after internship in Uppsala completed a fellowship in Pediatrics (1987) in Stockholm. Defended a PhD-thesis at Karolinska Institutet in 1990, with focus on hemophagocytic lymphohistiocytosis (HLH).
Specialized clinically in Pediatric Hematology and Oncology, and became Professor at Karolinska Institutet in 2004.
Director of Research and Education at Karolinska University Hospital 2012-2017.
The main research interest is within the histiocytic disorders, including Hemophagocytic Lymphohistiocytosis (HLH) and Langerhans cell histiocytosis (LCH).
In addition to developing the first diagnostic criteria for HLH, PI of HLH-94 as well as HLH-2004. Studied underlying biological and genetic defects in HLH. Another interest is the secondary forms of HLH.
Increasingly interested in clinical and biological studies of Langerhans cell histiocytosis (LCH), with the ultimate aim to reduce morbidity and mortality.
In addition, interests in many other fields including End-of-Life Care and Rare Diseases.
President of the Histiocyte Society 2004-2007, and the Founding President of the International Conference for Rare Diseases and Orphan Drugs (ICORD).
1973-1980 University Medical Degree (M.D.), University of Uppsala
1976-1979 Bachelor of Science in Economics (B. Sc.), University of Uppsala
1980-1981 Licensed physician.
1982-1987 Board Certified Specialist in Pediatrics
1986-1990 Dr Med Sci (Ph.D.), Dept of Pediatrics, Karolinska Institutet
Academic honours, awards and prizes
2002: Jubilee Prize Winner of the Children´s Cancer Foundation of Sweden. (“Barncancerfondens Jubileumspris”)
2003: Alvarengas Prize, awarded by the Swedish Society of Medicine.
2011: Lennander’s Award, awarded by the Swedish Society of Medicine.
2011: The Jubilee Prize awarded by the Swedish Society of Medicine 2011 (“Svenska Läkaresällskapets Jubileumspriset 2011”)